Clinical Trial Update: Efficacy Study of Fluconazole to Treat Coccidioidomycosis Pneumonia (Valley Fever) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating efficacy of fluconazole for coccidioidomycosis pneumonia (valley fever) was terminated; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coccidioidomycosis

Drugs mentioned

• Fluconazole (Fluconazole)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Coccidioidomycosis | Phase 4 | Status: TERMINATED | Results posted: 2019-07-05